記憶度
8問
24問
0問
0問
0問
アカウント登録して、解答結果を保存しよう
問題一覧
1
the study of pharmacotechnical factors in the drug products that ccan affect the pharmacokinetics of drugs -study of dosage forms and its dissolution properties
biopharmaceutics
2
study of the pocess that a drug undergoes from the moment it enters the body unti it leaves - what the body doesto the drug
pharmacokinetics
3
THE ONLY BIOPHARMACEUTICS PROCESS -the process of converting the drug product to its solution form -a highly modifiable process and is considered as one of the primary determinants of the onset of action and duration of action
liberation
4
rate and extent of drug entry into the sytemic circulation
absorption
5
movement of drug from systemic circulation to different compartments
distribution
6
process of converting drugs to a less active form
metabolism
7
a space in the body pertaining to organs and tissues deemed as kinetically homogenous
compartments
8
*a measure of how much the concentration changes from one compartment to another
concentration gradient
9
the process of removing or introducing a substance to a compartment
transport
10
ionized
charged
11
unionized
uncharged
12
dominates when a substance is introduced to an environment with OPPOSITE ph
ionized
13
dominates when a substance isintrodced to an environment with the SAME ph
unionized
14
dissolution is governed by what equation
noyes-whitney
15
intrasynovial
joint fluid area
16
intraarticular
joint space
17
intrathecal
cerebrospinal
18
lowest possible concentration to cause an effect
minimum effective concentration
19
minimum toxic concentration is the highest concentration possible to cause an effect without any toxic effects
maximum therapeutic concentration
20
-high doseing frequency------ risk of noncompliace especially if polypharmacy -has the least lag time/liberation -fast onset, short duration
immediate release
21
-follows immediate release graph but allows for a second release -fast onset
bimodal release
22
-lag time is longer than that of the immediate release graph but allows for a second release graph -slow onset, short duration
delayed release
23
-used to lower frequency of dosing -fast onset, long duration
extnded release
24
ratio of solubility in oil and water
partition coefficient
25
high partition coefficient
lipid soluble
26
low partition coefficient
water soluble
27
ionized-water soluble
dissolution
28
unionized-lipid soluble
absorption
29
amorphous form is more easily soluble than its crystallne form
polymrphism
30
recemic- equal portions of levo and dextro isomers
chirality
31
-makes nonpolar drugs soluble in polar solvents
slt formation
32
compounnds containing water, making it easier to dissolve
hydrates
33
creates a bigger compoud, making it less soluble
complex formation
34
who proposed the theory of cell membranes
davson and danieli
35
two layers of phospholipids wiith the hydrophilic heads faciing outside and the hydrophobic tails inside
unit membrane theory/lipid bilayer
36
the lipid bilayer has proteins embedded in the matrix
fluid mosaic model
37
proteins embedded in the matrix are used as receptors and for transport
modified fuid mosaic
38
-most common but slowest -moves along the concentration gradient an therefore does not need ATP -does not need any carrier -based on fick's law of diffusion
passive diffusion
39
-rate of diffusion is directly proportional to partition coefficient, surface area, concentration gradient -rate of diffusion is inversely proportional to the thickness of the membrane
fick's law
40
-stereo specific -competetive and saturable -follow michaeli menten kinetics
carrier-mediated transport
41
direction of facilitated diffusion
alonng the concentration gradient
42
direction of active transport
against the concentration gradient
43
-via water filled pores or channels -along the concentration gradient -solvent drag- ions move along the same direction as water -opposite charges -MW: 150-400 -transport system used by electrolytes
convective transport
44
drug ions bind to endogenous ions to form a neutral complex which is uncharged and is capable of passive diffusion
ion pair transport
45
-envagenation of cell membrane *phagocytosis *endocytosis *pinocytosis *exocytosis
vesicular transport
46
the measure of rate and extent of drug entry into the sytemic circulation
bioavailability
47
maximum plasma concentration -most variable parameter -measures rate and extent
cmax
48
time it takes to reach cmax -measures rate
tmax
49
area under the curve -measures extent
auc
50
the ratio of generic to innovator in terms of the pharmacokinetic parameters of biovailability
bioequivalence
51
same in all aspects but may differ in excipients
pharmaceutical equivalent
52
same API, different dose or dosage form
pharmaceutical alternative
53
same safety and efficacy- bioequivlent and phharmaceutical equivalent
therapeutic equivalent
54
different api, same drug class
therapeutic alternative
55
classification of drugs based on dissolution and intestinal permeability, which affects absorption of the API
biopharmaceutics classification system
56
cardiac output regional blood flow
physiological factors
57
for acidic drugs
albumin
58
for hormones
globulin
59
allows exchange of nutrients between the mother and the fetus
placetal barrier